Table 1. Summary of the Clinicopathological Features of Patients and Gene Statuses of Derived Cell Lines1.
| Cell lines | Sex | Age | Stage (TNM) | Tumor Site | K-ras | SMAD43 | TP53 |
|---|---|---|---|---|---|---|---|
| MDA-PATC43 | F | 71 | 3.0.0 | Pancreas | Cod 12: GGT;CGT | Delete | WT |
| MDA-PATC50 | F | 60 | 3.1.0 | Pancreas | Cod 12: GGT;CGT | Delete | C(945,1061)>T |
| MDA-PATC532 | M | 65 | X.X.1 | Liver | Cod 12: GGT;GAT | WT4 | WT4 |
| MDA-PATC66 | F | 63 | 3.1.0 | Pancreas | Cod 12: GGT; GAT | Delete | T(909,591)>A |
All of these patients had no pre-operative treatment, and tumor tissue was confirmed pancreatic adenocarcinoma.
Tumor from liver metastasis site.
Expression of SMAD4 protein was also demonstrated by immunohistochemistry in both patient specimens and murine xenograft tissue (Figure 3.).
Wild Type.